Question 1

Has Audrey Fetch, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $85 in general payments to Audrey Fetch, MD across 4 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Audrey Fetch, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Audrey Fetch, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Revance Therapeutics, Inc.	2	$41
Regeneron Healthcare Solutions, Inc.	1	$34
Organon	1	$11

Drug	Claims	Cost to plans & patients
Fluorouracil	39	$2,797
Ketoconazole	38	$630
Betamethasone Dipropionate	15	$575
Triamcinolone Acetonide	30	$212
Mupirocin	11	$160
Hydrocortisone	20	$78

Audrey Fetch, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other dermatology in Menlo Park